Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Triamcinolone Acetonide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 known ✓ | P04150 | 7/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 9/20 | 0.69 |
| ▸ | PGR | P06401 | 7/20 | 0.69 |
| ▸ | LMNA | P02545 | 6/20 | 0.69 |
| ▸ | HIF1A | Q16665 | 6/20 | 0.69 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.62 |
| ▸ | ABCB11 | O95342 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.62 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | HTR1A | P08908 | 1/20 | 0.58 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.58 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | AR | P10275 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triamcinolone SCHEMBL3880195 | 0.88 | CYP3A4 (0.69) | CYP3A4NR3C1PGRLMNAHIF1A | |
| Triamcinolone Acetonide SCHEMBL20915153 | 0.88 | HIF1A (0.77) | CYP3A4NR3C1PGRLMNAHIF1A | |
| Triamcinolone SCHEMBL22494815 | 0.87 | CYP3A4 (0.68) | CYP3A4NR3C1PGRLMNAHIF1A | |
| Betamethasone SCHEMBL20576476 | 0.87 | CYP3A4 (0.69) | CYP3A4NR3C1PGRLMNAHIF1A | |
| Dexamethasone SCHEMBL3877338 | 0.87 | CYP3A4 (0.69) | CYP3A4NR3C1PGRLMNAHIF1A | |
| Triamcinolone Acetonide SCHEMBL17785112 | 0.86 | HIF1A (0.76) | CYP3A4NR3C1PGRLMNAHIF1A | |
| Flunisolide SCHEMBL20915050 | 0.85 | CYP3A4 (0.69) | CYP3A4NR3C1PGRLMNAHIF1A | |
| Dexamethasone SCHEMBL20767432 | 0.85 | CYP3A4 (0.66) | CYP3A4NR3C1PGRLMNAHIF1A | |
| Triamcinolone Acetonide SCHEMBL11911289 | 0.83 | HIF1A (1.00) | CYP3A4NR3C1PGRLMNAHIF1A | |
| Triamcinolone Acetonide SCHEMBL1639690 | 0.83 | HIF1A (1.00) | CYP3A4NR3C1PGRLMNAHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070049901-A1 | Method of treating acne with stratum corneum piercing device | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. | 2007-03-01 | — | — | US | disclosed |